Annual Revenue
$126.33 M
+$119.20 M+1672.24%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual revenue is $126.33 million, with the most recent change of +$119.20 million (+1672.24%) on December 31, 2023.
- During the last 3 years, MCRB annual revenue has risen by +$93.11 million (+280.33%).
- MCRB annual revenue is now -12.84% below its all-time high of $144.93 million, reached on December 31, 2021.
Performance
MCRB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- MCRB quarterly revenue is not available.
Performance
MCRB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- MCRB TTM revenue is not available.
Performance
MCRB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MCRB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1672.2% | - | - |
| 3 y3 years | +280.3% | - | - |
| 5 y5 years | +346.9% | - | - |
MCRB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | +1672.2% | ||||
| 5 y | 5-year | -12.8% | +1672.2% | ||||
| alltime | all time | -12.8% | +1672.2% |
Seres Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $126.33 M(+1672.2%) | $126.33 M(-0.1%) | $252.28 M(+93.5%) |
| Jun 2023 | - | $126.47 M(<-9900.0%) | $130.37 M(+2449.8%) |
| Mar 2023 | - | -$522.00 K(-153.5%) | $5.11 M(-28.3%) |
| Dec 2022 | $7.13 M(-95.1%) | $975.00 K(-71.7%) | $7.13 M(-50.7%) |
| Sep 2022 | - | $3.44 M(+183.2%) | $14.44 M(-89.5%) |
| Jun 2022 | - | $1.22 M(-18.6%) | $137.72 M(-2.9%) |
| Mar 2022 | - | $1.49 M(-82.0%) | $141.77 M(-2.9%) |
| Dec 2021 | $144.93 M(+336.3%) | $8.29 M(-93.5%) | $146.00 M(-6.0%) |
| Sep 2021 | - | $126.72 M(+2307.8%) | $155.27 M(+418.2%) |
| Jun 2021 | - | $5.26 M(-8.0%) | $29.96 M(-2.5%) |
| Mar 2021 | - | $5.72 M(-67.4%) | $30.74 M(-7.4%) |
| Dec 2020 | $33.22 M(-3.7%) | $17.56 M(+1139.5%) | $33.22 M(+42.7%) |
| Sep 2020 | - | $1.42 M(-76.6%) | $23.27 M(-19.4%) |
| Jun 2020 | - | $6.04 M(-26.2%) | $28.89 M(-18.3%) |
| Mar 2020 | - | $8.19 M(+7.4%) | $35.37 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $34.51 M(+22.1%) | $7.62 M(+8.4%) | $34.51 M(-8.0%) |
| Sep 2019 | - | $7.03 M(-43.9%) | $37.51 M(-5.1%) |
| Jun 2019 | - | $12.53 M(+71.2%) | $39.54 M(+25.0%) |
| Mar 2019 | - | $7.32 M(-31.1%) | $31.62 M(+11.9%) |
| Dec 2018 | $28.27 M(-11.9%) | $10.63 M(+17.4%) | $28.27 M(+36.6%) |
| Sep 2018 | - | $9.05 M(+96.3%) | $20.69 M(-40.3%) |
| Jun 2018 | - | $4.61 M(+16.1%) | $34.65 M(+4.8%) |
| Mar 2018 | - | $3.97 M(+29.9%) | $33.06 M(+3.0%) |
| Dec 2017 | $32.10 M(+47.5%) | $3.06 M(-86.7%) | $32.10 M(+0.1%) |
| Sep 2017 | - | $23.02 M(+663.6%) | $32.08 M(+45.3%) |
| Jun 2017 | - | $3.01 M(-0.0%) | $22.08 M(+0.0%) |
| Mar 2017 | - | $3.02 M(-0.7%) | $22.07 M(+1.4%) |
| Dec 2016 | $21.77 M | $3.04 M(-76.7%) | $21.77 M(+16.2%) |
| Sep 2016 | - | $13.02 M(+333.3%) | $18.73 M(+227.8%) |
| Jun 2016 | - | $3.00 M(+10.8%) | $5.71 M(+110.8%) |
| Mar 2016 | - | $2.71 M | $2.71 M |
FAQ
- What is Seres Therapeutics annual revenue?
- What is the all time high annual revenue for Seres Therapeutics?
- What is Seres Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Seres Therapeutics?
- What is the all time high TTM revenue for Seres Therapeutics?
What is Seres Therapeutics annual revenue?
The current annual revenue of MCRB is $126.33 M
What is the all time high annual revenue for Seres Therapeutics?
Seres Therapeutics all-time high annual revenue is $144.93 M
What is Seres Therapeutics annual revenue year-on-year change?
Over the past year, MCRB annual revenue has changed by +$119.20 M (+1672.24%)
What is the all time high quarterly revenue for Seres Therapeutics?
Seres Therapeutics all-time high quarterly revenue is $126.72 M
What is the all time high TTM revenue for Seres Therapeutics?
Seres Therapeutics all-time high TTM revenue is $252.28 M